Email Newsletters

Life Sciences

Akoya Biosciences to be acquired by Billerica research firm, create $220M business

To further its efforts in advancing spatial biology imaging, Marlborough-based biotech firm  Akoya Biosciences has agreed to be acquired by Quanterix, a Billerica-based research corporation.

Boston Scientific promotes HR executive to chief human resources officer

Marlborough medical device manufacturer Boston Scientific has promoted Miriam O’Sullivan to the C-suite position senior vice president and chief human resources officer.

Report: State’s biopharma industry see signs of a rebound as Central Mass. companies received $249M in venture capital in 2024

This increase in funding is the first year-over-year increase since the COVID-19 pandemic.

Boston Scientific to acquire California blood flow treatment manufacturer for up to $664M

Marlborough-based Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment manufacturer Bolt Medical.
ADVERTISEMENT

Allurion appoints former life sciences interim CEO to expanding board of directors

Weight-loss tech company Allurion Technologies has expanded its board of directors, appointing Jason Richey on Dec. 30 as the Natick publicly traded company’s ninth member.

Hologic completes $350M acquisition of California women’s health device manufacturer

Marlborough-based medical device manufacturer Hologic has closed its acquisition of Gynesonics.

🔒WBJ’s 10 bold predictions for 2025

Every December for this Economic Forecast special edition, the journalists in the WBJ newsroom forecast 10 possible news events for the coming year, based on their expertise and the trends in the Central Massachusetts business community.
ADVERTISEMENT

After two patient deaths, Boston Scientific recalls pacemaker

Boston Scientific, a Marlborough medical device manufacturer, has recalled a subset of its Accolade pacemakers due to battery issues leading to malfunctions, where two patient deaths have been reported. 

WuXi construction resumes at delayed $300M facility as BIOSECURE Act stalls

A pause in construction of the $300-million WuXi Biologics manufacturing facility at The Reactory biotech park in Worcester appears to be over.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

Retail and Customer Service Specialist

Girl Scouts of Central and Western Massachusetts
,
Worcester, MA
$20/hour

Communications & Events Coordinator

Girls Inc. of Worcester
,
Worcester, MA
Hourly Rate: $24–$27.88/hr (based on experience)

Chief Financial Officer

The Girl Scouts of Central and Western Massachusetts
,
Worcester, MA
$125,000 - $135,000
More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA